Molecular Biology of the Cell track citations

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E05-04-0375 on December 21, 2005

Vol. 17, Issue 3, 1075-1084, March 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
E05-04-0375v1
17/3/1075    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laser, H.
Right arrow Articles by Coleman, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laser, H.
Right arrow Articles by Coleman, M. P.

The Slow Wallerian Degeneration Protein, WldS, Binds Directly to VCP/p97 and Partially Redistributes It within the NucleusFormula

Heike Laser * {dagger} {ddagger}, Laura Conforti {dagger} §, Giacomo Morreale §, Till G.M. Mack *, Molly Heyer §, Jane E. Haley ||, Thomas M. Wishart ||, Bogdan Beirowski *, Simon A. Walker §, Georg Haase ¶, Arzu Celik *, Robert Adalbert §, Diana Wagner *, Daniela Grumme *, Richard R. Ribchester ||, Markus Plomann #, and Michael P. Coleman * §

* Institute for Genetics and Center for Molecular Medicine, University of Cologne, D-50674 Cologne, Germany; § The Babraham Institute, Babraham, Cambridge CB2 4AT, United Kingdom; || Division of Neuroscience, University of Edinburgh, Edinburgh EH8 9JZ, United Kingdom; Avenir Team, INSERM U29, INMED, Luminy, 13273 Marseille Cedex 09, France; and # Center for Biochemistry and Center for Molecular Medicine Cologne, University of Cologne, D-50931 Cologne, Germany

Submitted May 2, 2005; Revised November 28, 2005; Accepted December 2, 2005
Monitoring Editor: Jeffrey Brodsky

Slow Wallerian degeneration (WldS) mutant mice express a chimeric nuclear protein that protects sick or injured axons from degeneration. The C-terminal region, derived from NAD+ synthesizing enzyme Nmnat1, is reported to confer neuroprotection in vitro. However, an additional role for the N-terminal 70 amino acids (N70), derived from multiubiquitination factor Ube4b, has not been excluded. In wild-type Ube4b, N70 is part of a sequence essential for ubiquitination activity but its role is not understood. We report direct binding of N70 to valosin-containing protein (VCP; p97/Cdc48), a protein with diverse cellular roles including a pivotal role in the ubiquitin proteasome system. Interaction with WldS targets VCP to discrete intranuclear foci where ubiquitin epitopes can also accumulate. WldS lacking its N-terminal 16 amino acids (N16) neither binds nor redistributes VCP, but continues to accumulate in intranuclear foci, targeting its intrinsic NAD+ synthesis activity to these same foci. Wild-type Ube4b also requires N16 to bind VCP, despite a more C-terminal binding site in invertebrate orthologues. We conclude that N-terminal sequences of WldS protein influence the intranuclear location of both ubiquitin proteasome and NAD+ synthesis machinery and that an evolutionary recent sequence mediates binding of mammalian Ube4b to VCP.


This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E05–04–0375) on December 21, 2005.

Abbreviations used: DRG, dorsal root ganglion; ERAD, endoplasmic reticulum-associated protein degradation; IVTT, in vitro transcription and translation; N16, N-terminal 16 amino acids of WldS and Ube4b; N70, N-terminal 70 amino acids of WldS and Ube4b; Nmnat1, nicotinamide mononucleotide adenylyltransferase; Ube4b, ubiquitination factor E4b; Ufd2, ubiquitin fusion degradation protein 2; UPS, ubiquitin proteasome system; VCP, valosin-containing protein; WldS, slow Wallerian degeneration gene or protein.

Formula The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).

{dagger} These authors contributed equally to this work.

{ddagger} Present address: International University Bremen, D-28759 Bremen, Germany.

Address correspondence to: Michael P. Coleman (michael.coleman{at}bbsrc.ac.uk).




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
T. M. Wishart, J. M. Paterson, D. M. Short, S. Meredith, K. A. Robertson, C. Sutherland, M. A. Cousin, M. B. Dutia, and T. H. Gillingwater
Differential Proteomics Analysis of Synaptic Proteins Identifies Potential Cellular Targets and Protein Mediators of Synaptic Neuroprotection Conferred by the Slow Wallerian Degeneration (Wlds) Gene
Mol. Cell. Proteomics, August 1, 2007; 6(8): 1318 - 1330.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Sasaki, T. Araki, and J. Milbrandt
Stimulation of Nicotinamide Adenine Dinucleotide Biosynthetic Pathways Delays Axonal Degeneration after Axotomy.
J. Neurosci., August 15, 2006; 26(33): 8484 - 8491.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2006 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.